ProstACT Global Phase 3 Update: First Patient Dosed, Part 1 Preliminary Data Plans ConfirmedTelix recently announced that its lead prostate cancer candidate TLX591 (lutetium-177 ro...
Obesity has become a major global public health challenge. According to the World Obesity Federation, approximately 3 billion people worldwide were overweight or obese by 2024. Exc...